Notes sold for $1.7 million; investors receive 120% warrant coverage
By Devika Patel
Knoxville, Tenn., Dec. 16 - 22nd Century Group, Inc. sold about $1.9 million of convertible promissory notes for roughly $1.7 million in a private placement on Dec. 14, according to an 8-K filed Friday with the Securities and Exchange Commission. The notes were sold with an original issue discount of about 15%.
The convertible promissory notes mature on Dec. 14, 2012, and the company may force conversion under some circumstances. The notes are convertible into common stock at $0.75 per share, which is a 16.67% discount to the Dec. 13 closing share price of $0.90.
Investors also received 120% warrant coverage. The warrants are each exercisable at $1.50 for five years. The strike price is a 66.67% premium to the Dec. 13 closing share price.
22nd Century is a Williamsville, N.Y., plant biotechnology company. Its proprietary technology allows for the level of nicotine and other nicotinic alkaloids in the tobacco plant to be decreased or increased through genetic engineering and breeding.
Issuer: | 22nd Century Group, Inc.
|
Issue: | Convertible promissory notes
|
Amount: | $1.9 million (approximate)
|
Maturity: | Dec. 14, 2012
|
Price: | $1.7 million (approximate), a 15% discount
|
Conversion price: | $0.75
|
Call: | Yes
|
Warrants: | 120% coverage
|
Warrant expiration: | Five years
|
Warrant strike price: | $1.50
|
Settlement date: | Nov. 1
|
Stock symbol: | Pink Sheets: XXII
|
Stock price: | $0.90 at close Nov. 1
|
Market capitalization: | $23.72 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.